全文获取类型
收费全文 | 252篇 |
免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 5篇 |
妇产科学 | 2篇 |
基础医学 | 22篇 |
口腔科学 | 7篇 |
临床医学 | 14篇 |
内科学 | 57篇 |
皮肤病学 | 1篇 |
神经病学 | 2篇 |
特种医学 | 6篇 |
外科学 | 37篇 |
综合类 | 2篇 |
预防医学 | 4篇 |
药学 | 12篇 |
肿瘤学 | 85篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 6篇 |
2019年 | 3篇 |
2018年 | 14篇 |
2017年 | 3篇 |
2016年 | 1篇 |
2015年 | 5篇 |
2014年 | 7篇 |
2013年 | 13篇 |
2012年 | 15篇 |
2011年 | 13篇 |
2010年 | 7篇 |
2009年 | 10篇 |
2008年 | 15篇 |
2007年 | 7篇 |
2006年 | 9篇 |
2005年 | 14篇 |
2004年 | 10篇 |
2003年 | 13篇 |
2002年 | 10篇 |
2001年 | 10篇 |
2000年 | 10篇 |
1999年 | 5篇 |
1998年 | 4篇 |
1997年 | 1篇 |
1996年 | 3篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1991年 | 6篇 |
1990年 | 3篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有259条查询结果,搜索用时 15 毫秒
31.
32.
Interleukin-11 induces Th2 polarization of human CD4(+) T cells 总被引:8,自引:1,他引:8
Curti A Ratta M Corinti S Girolomoni G Ricci F Tazzari P Siena M Grande A Fogli M Tura S Lemoli RM 《Blood》2001,97(9):2758-2763
Exploration of the immunomodulatory activities of the multifunctional cytokine interleukin-11 (IL-11) has prompted several therapeutic applications. The immunomodulatory effects of IL-11 on human antigen-presenting cells and on T cells were investigated. IL-11 inhibited IL-12 production by activated CD14(+) monocytes, but not by mature dendritic cells (DCs) stimulated via CD40 ligation. Moreover, IL-11 did not affect either DC maturation, as demonstrated by phenotypic analysis and evaluation of cytokine production, or DC generation from progenitor cells in the presence of specific growth factors. Molecular analysis demonstrated the expression of IL-11 receptor messenger RNA in highly purified CD14(+) monocytes, CD19(+) B cells, CD8(+), and CD4(+) T cells, and CD4(+)CD45RA(+) naive T lymphocytes. In keeping with this finding, IL-11 directly prevented Th1 polarization of highly purified CD4(+)CD45RA(+) naive T cells stimulated with anti-CD3/CD28 antibodies, as demonstrated by significant increases of IL-4 and IL-5, by significantly decreased interferon-gamma production and by flow cytometry intracellular staining of cytokines. Coincubation of naive T cells with DCs, the most potent stimulators of Th1 differentiation, did not revert IL-11-mediated Th2 polarization. Furthermore, parallel experiments demonstrated that the activity of IL-11 was comparable with that induced by IL-4, the most effective Th2-polarizing cytokine. Taken together, these findings show that IL-11 inhibits Th1 polarization by exerting a direct effect on human T lymphocytes and by reducing IL-12 production by macrophages. Conversely, IL-11 does not exert any activity on DCs. This suggests that IL-11 could have therapeutic potential for diseases where Th1 responses play a dominant pathogenic role. 相似文献
33.
Pedrazzoli P Ferrante P Kulekci A Schiavo R De Giorgi U Carminati O Marangolo M Demirer T Siena S Rosti G;European Group for Blood Marrow Transplantation 《Bone marrow transplantation》2003,32(5):489-494
The aim of this study was to identify trends in high-dose chemotherapy (HDC) with autologous hematopoietic stem cell transplantation (ASCT) and to assess survival in a large cohort of breast cancer (BC) patients receiving this therapy in Europe from 1990 to 1999. A total of 7471 patients who received HDC with ASCT between January 1, 1990 and December 31, 1999 were reported to the European Group for Blood and Marrow Transplantation Registry. Data required for demographics and survival analysis were available for 2679 patients with high-risk primary BC; 921 patients with inflammatory BC (IBC), and 2295 patients with metastatic disease. The main evaluation parameters were progression-free survival (PFS) and overall survival (OS). Between 1990 and 1998, autotransplants for BC increased 30-fold. Significant trends included use of blood-derived rather than marrow-derived stem cells, increment of reporting centers and decrease of mortality within 100 days from transplantation. The 5-year PFS and OS probabilities were 53 and 68% for high-risk disease and 42 and 53% for IBC, respectively. For metastatic disease 5-year PFS and OS probabilities in the whole cohort were 18 and 27%, respectively, while for women transplanted in complete remission the 5-year PFS was 29%. In conclusion, HDC with ASCT has been increasingly used until 1998 and the 100-day mortality rate has been constantly less than 2% from 1995 to date. The 5-year survival of high-risk BC is related to the number of axillary nodes involved at surgery. Outcome of patients with IBC is encouraging, suggesting the need for randomized trials. Patients with metastatic disease responding to pretransplant chemotherapy and harboring ER+ tumors have a better outcome. 相似文献
34.
Stefano Corbella Luca Francetti Silvio Taschieri Francesca De Siena Massimo Del Fabbro 《Journal of diabetes investigation.》2013,4(5):502-509
Aims/Introduction
The aim of the present study was to investigate whether non‐surgical periodontal treatment reduces glycated hemoglobin (HbA1c) and fasting plasma glucose (FPG) levels in diabetic patients.Materials and Methods
An electronic search was carried out on MEDLINE (through PubMed interface), EMBASE and the Cochrane Central Register of Controlled Trials. Randomized controlled trials with a minimum of 3 months follow up were included. The risk of bias was assessed for each study. A meta‐analysis was carried out to evaluate the effect of non‐surgical periodontal treatment on HbA1c and FPG levels. The effect of the adjunctive use of antimicrobials was also assessed.Results
A total of 15 studies were included. A reduction of −0.38% (95% confidence interval [CI] −0.23 to −0.53) after 3–4 months (P < 0.001) and of −0.31% (95% CI 0.11 to −0.74) after 6 months (P = 0.15) of follow‐up was found for HbA1c, favoring the treatment group. Similarly, in treated patients, a significantly greater decrease in FPG was observed in respect to control participants. Such difference amounted to −9.01 mg/dL (95% CI −2.24 to −15.78) after 3–4 months (P = 0.009) and −13.62 mg/dL (95% CI 0.45 to −27.69) after 6 months (P = 0.06) from treatment, respectively. In participants treated with adjunctive antimicrobials, a non‐significant increase of HbA1c was observed 3 months after treatment, whereas FPG decreased by 0.27 mg/dL (95% CI 39.56 to −40.11; P = 0.99).Conclusions
The meta‐analysis showed that non‐surgical periodontal treatment improves metabolic control in patients with both periodontitis and diabetes. 相似文献35.
In 1990, high-dose chemotherapy, with or without radiotherapy, requiring the support of hematopoietic stem cell transplantation has been confirmed as an effective treatment modality for a fraction of recurring or refractory lymphomas. Most relevant clinical studies published in 1990 are summarized and commented on in this review. Upcoming developments expected to improve the therapeutic index of high-dose therapies comprise the identification of patients at high risk of relapse so they can be treated earlier in the course of the disease, and the utilization of hematopoietic growth factors for ameliorating myelosuppression, as well as for harvesting peripheral blood hematopoietic stem cells utilizable for transplantation. 相似文献
36.
Ricotta R Cerea G Schiavetto I Maugeri MR Pedrazzoli P Siena S 《Future oncology (London, England)》2006,2(6):667-676
Myeloid colony-stimulating factors (granulocyte colony-stimulating factor [G-CSF] and granulocyte-macrophage colony-stimulating factor) are commonly used in clinical practice for the prevention of anticancer chemotherapy-induced neutropenia and its potentially life-threatening complications. Pegfilgrastim is a novel recombinant human G-CSF pharmaceutically developed by covalent binding of a polyethylene glycol molecule to the N-terminal sequence of filgrastim. Due to its unique neutrophil-mediated clearance, pegfilgrastim can be administered once per chemotherapy cycle. Clinical trials have demonstrated that a single, fixed, subcutaneous dose of pegfilgrastim is comparable in safety and efficacy to daily injections of filgrastim for decreasing the incidence of infection following myelosuppressive chemotherapy in patients with cancer. Recent trials have been conducted to evaluate the use of pegfilgrastim in different clinical settings, including support of dose-dense regimens, mobilization and transplantation of hematopoietic stem cells. 相似文献
37.
A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents 总被引:1,自引:0,他引:1
Selleri S Bruni F Costagli C Costanzo A Guerrini G Ciciani G Gratteri P Besnard F Costa B Montali M Martini C Fohlin J De Siena G Aiello PM 《Journal of medicinal chemistry》2005,48(21):6756-6760
In our pursuit to identify selective ligands for Bz/GABA(A) receptor subtypes, a novel pyrazolo[1,5-a]pyrimidine derivative (4), the azaisostere of zolpidem, was synthesized and evaluated in vitro on bovine brain homogenate and on recombinant benzodiazepine receptors (alphaxbeta2/3gamma2, x = 1-3, 5) expressed in HEK293 cells. Compound 4 displayed affinity only for alpha1beta2gamma2 subtype (K(i) = 31 nM), and in an in-depth, in vivo study it revealed sedative and anxiolytic-like properties without any amnesic and myorelaxant effects in rodents. 相似文献
38.
Corbella S Del Fabbro M Taschieri S De Siena F Francetti L 《International journal of dental hygiene》2011,9(3):216-222
To cite this article: Int J Dent Hygiene 9 , 2011; 216–222DOI: 10.1111/j.1601‐5037.2010.00489.xCorbella S, Del Fabbro M, Taschieri S, De Siena F, Francetti L. Clinical evaluation of an implant maintenance protocol for the prevention of peri‐implant diseases in patients treated with immediately loaded full‐arch rehabilitations. Abstract: Objective: The aim of this prospective study was to assess the outcomes of an implant maintenance protocol for implants supporting a full‐arch rehabilitation. Materials and methods: Sixty‐one patients (28 women and 33 men) treated with immediately loaded full‐arch rehabilitation, both mandibular and maxillary, supported by a combination of two tilted and two axial implants, were included in the study. Patients were scheduled for follow‐up visits every 6 months for +2 years, then yearly up to 4 years. Each patient received professional oral hygiene treatment and detailed oral hygiene instructions. During each visit, modified plaque index, bleeding index and probing depth were assessed. The presence of peri‐implant tissue inflammation was also evaluated. Results: Mean observation time, considering both mandible and maxilla, was 18.3 months ranging from 6 months to 5 years. Both plaque and bleeding indexes frequency decreased over time. Probing depth was stable (2.46 ± 0.5 mm at 4 years). Only three implants were lost due to peri‐implantitis (1.4% at 12 months), whereas the incidence of peri‐implant mucositis was less than 10% in each considered period. Conclusions: The adoption of a systematic hygienic protocol is effective in keeping low the incidence of peri‐implant mucositis as well as in controlling plaque accumulation and clinical attachment loss. 相似文献
39.
Elena Ardini Roberta Bosotti Andrea Lombardi Borgia Cristina De Ponti Alessio Somaschini Rosaria Cammarota Nadia Amboldi Laura Raddrizzani Andrea Milani Paola Magnaghi Dario Ballinari Daniele Casero Fabio Gasparri Patrizia Banfi Nilla Avanzi Maria B. Saccardo Rachele Alzani Tiziano Bandiera Eduard Felder Daniele Donati Enrico Pesenti Andrea Sartore-Bianchi Marcello Gambacorta Marco A. Pierotti Salvatore Siena Silvio Veronese Arturo Galvani Antonella Isacchi 《Molecular oncology》2014,8(8):1495-1507
40.
Siena L Gjomarkaj M Elliot J Pace E Bruno A Baraldo S Saetta M Bonsignore MR James A 《Respiratory medicine》2011,105(10):1491-1500
Chronic obstructive pulmonary disease (COPD) is characterised by chronic inflammation in airways and lung parenchyma. CD8+ T-lymphocytes, crucial effector and regulatory cells in inflammation, are increased in the central and peripheral airways in COPD. The aim of this study was to assess the role of apoptosis in the accumulation of CD8+ T-lymphocytes within the airway wall in COPD. We examined the submucosa of transverse sections of central and peripheral airways from post-operative tissues from non-smokers (n?=?16), smokers with normal lung function (n?=?16), smokers with mild/moderate COPD (n?=?16), and smokers with severe/very severe COPD (n?=?9). TUNEL and immunohistochemistry techniques were used to identify apoptosis and cell phenotype, respectively. The percentage of apoptotic CD8+ T-lymphocytes was significantly lower (p?0.0001) in smokers with mild/moderate COPD than in non-smokers, smokers with normal lung function, and smokers with severe/very severe COPD, and was positively related to values of FEV(1) and FEV(1)/FVC ratio, both in central and in peripheral airways. These data suggest that reduced apoptosis of CD8+ T-lymphocytes may be an important mechanism that contributes to the accumulation of these cells in the airway submucosa in smokers with mild/moderate COPD. 相似文献